NCT05230290View on ClinicalTrials.gov

Clinical Study of KD6001 in Advanced Solid Tumours

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 10, 2020

Primary Completion Date

July 20, 2022

Study Completion Date

July 26, 2022

Conditions
Solid Tumor
Interventions
BIOLOGICAL

KD6001 Injection

Solution for intravenous injection

Trial Locations (1)

Unknown

Beijing Cancer Hospital, Beijing

All Listed Sponsors
lead

Shanghai Kanda Biotechnology Co., Ltd.

INDUSTRY

NCT05230290 - Clinical Study of KD6001 in Advanced Solid Tumours | Biotech Hunter | Biotech Hunter